Today, Center for Translational Research AB (CTR) announced three major internal leadership changes within the corporate group, with new CEOs for CTC Clinical Trial Consultants AB (CTC) and Toxicology Knowledge Team Sweden AB (TKT), and a new role as Chief Commercial Officer for CTC’s current CEO Anders Millerhovf. The upcoming role changes at CTR, CTC and TKT reflect the positive growth of the corporate group, and an increasing customer demand for the involvement of several subsidiaries within the same project.
- CTC’s current CEO Anders Millerhovf will take a dual role as Chief Commercial Officer at CTC and CTR.
- TKT’s current CEO Suzanne Iverson Hemberg is appointed as CEO of CTC.
- Anna Steneholm, presently Senior Toxicology Consultant at TKT, is appointed as CEO of the same company.
“These leadership transitions mark the next step in our journey, building on a proven record of growth, trust and customer value. As demand for our expertise and specialized services continues to rise, we will expand our capabilities to deliver even greater value to customers and partners. I am proud of our internal talents and grateful for the opportunity to foster leadership through internal career development,” says Karin Meyer, the CEO of CTR.
The largest company within the group, the full-service CRO CTC, has been successfully led by CEO Anders Millerhovf since 2015. Millerhovf will step into a new dual role as Chief Commercial Officer for CTC and CTR, focusing on driving customer relations and business development for CTC as well as the entire corporate group under CTR. Millerhovf, who holds an MSc in Medical Biology from Linköping University, co-founded CTC in 2011 and has thus been instrumental in leading CTC in becoming a market leader for early clinical trials in Northern Europe.
“After ten years as CEO, I feel both proud and grateful for the journey we have made together. It has been a privilege to lead CTC and to see what we have accomplished. Moving into my new role as Chief Commercial Officer gives me the opportunity to continue contributing to both CTC and CTR in new ways. I look forward to building the future together with our fantastic colleagues and clients – always true to our mission of translating science into treatment, with patients for patients,” says Anders Millerhovf.
Suzanne Iverson Hemberg, the current CEO of TKT, will become CEO of CTC. Iverson Hemberg brings broad experience from both the corporate and public healthcare sectors, having previously held Senior Director positions in Laboratory Medicine at Sahlgrenska University Hospital as well as principal scientific and middle management roles at AstraZeneca. She has a PhD in Pharmacology and Toxicology from the University of Toronto after which she undertook a postdoc in Molecular Toxicology at Karolinska Institutet. Iverson Hemberg will continue her involvement in TKT as a member of the board.
“Leaving my fantastic colleagues at TKT Sweden and following Anders as CEO of CTC are both challenging endeavours. As the new CEO of CTC, I am looking forward to combining my passion for the science behind development of safe and effective therapeutics with my energy, drive and solid track record in leading in a complex environment. I am privileged to have the opportunity to lead a company that has been built with dedicated leadership,” says Iverson Hemberg.
Anna Steneholm
Anna Steneholm, who has worked as Senior Toxicology Consultant at TKT since 2022, will take the role as CEO of the company. Steneholm holds a PhD in Toxicology from Karolinska Institutet, and has previously held senior roles within toxicology in the chemical and petroleum industry, for example with the trade organisation Concawe and Nynas AB.
“It’s exciting to take the step from specialist to CEO at TKT! Having an opportunity to lead such a competent and passionate team, which is set to grow in the coming years, feels incredibly inspiring. I look forward to our team’s continued contribution to the safety of pharmaceutical and chemical products, maintaining the same high quality, scientific curiosity, and integrity that’s the hallmark of the TKT team,” says Anna Steneholm.
These role changes will take effect during the last quarter of this year.
CONTACT
Karin Meyer, CEO, CTR AB
+46 768 559 648, Karin.Meyer@ctr-ab.se
Anders Millerhovf, CEO, CTC AB
+46 768 339 888, Anders.millerhovf@ctc-ab.se
Suzanne Iverson Hemberg, CEO, TKT AB
+46 730 75 36 82, Suzanne.iverson@tktsweden.com
ABOUT CTR AB
Center for Translational Research AB (CTR) was founded in 2016 with the aim to create a new structure for translational science in the life science sector in Northern Europe. CTR provides expert services and advice within life science product development. Currently, CTR has eight subsidiaries supporting the pharmaceutical and medical technology industry: CTC Clinical Trial Consultants AB, Lablytica Life Science AB, RegSmart Life Science AB, Toxicology Knowledge Team Sweden AB, Metasafe AB, QAlliance AB, CTC Netherlands BV and Zelmic AB. www.ctr-ab.se
ABOUT CTC AB
CTC Clinical Trial Consultants AB (CTC) is a full-service CRO company focusing on clinical trials. Our mission is to facilitate clinical and translational research by offering our clients cost-effective advice, planning, conduct, and reporting of clinical trials. Our studies are conducted both within our own site network – including six sites in Sweden located in Uppsala, Stockholm, Linköping, and Gothenburg, as well as one site in the Netherlands located in Groningen – and in collaboration with external sites, allowing us to tailor each study to the needs of our clients. Our clinics work closely with our departments for clinical operations, biometrics, pharmacovigilance, as well as DMPK & Clinical Pharmacology to offer a truly full-service option to our clients. www.ctc-ab.se
ABOUT TKT
Toxicology Knowledge Team Sweden AB (TKT) was founded in 2012 and is one of the largest toxicology consultant companies in the Nordic Region. Our areas of expertise include toxicological evaluations in all phases of drug development, drug manufacturing support and occupational safety, chemical product development as well as chemical product stewardship. www.tktsweden.com